Target intelligence / Profile preview

Gp41-1 split intein (Gp41-1)

Target
Gp41-1
Molecular classification
Enzyme, Autocatalytic protein, Protein splicing factor
01

Overview

The Gp41-1 split intein is a highly efficient protein splicing element derived from a cyanophage, consisting of N-terminal (IntN) and C-terminal (IntC) fragments. These fragments possess a high affinity for one another and, upon association, catalyze a self-excision process known as protein trans-splicing, which covalently links two flanking protein sequences (exteins) with a native peptide bond (PMID: 23933386, PMID: 21534051). In biotechnology and medicine, Gp41-1 is primarily utilized as a tool for protein engineering and gene therapy rather than serving as a traditional therapeutic target. It is frequently employed to circumvent the packaging limits of viral vectors, such as Adeno-associated virus (AAV), by splitting large therapeutic proteins into two halves that reconstitute functionally within the target cell (PMID: 31586043). While it is not a target for small molecule drugs, its kinetics and specificity make it a cornerstone of synthetic biology for the conditional activation of enzymes, transcription factors, and chimeric antigen receptors (CARs).

Other names
Gp41-1 N-inteinGp41-1 C-inteinGp41-1 protein splicing elementN-terminal intein fragmentC-terminal intein fragment
02

Mechanism of action

The Gp41-1 split intein fragments (IntN and IntC) undergo rapid and spontaneous association to form a functional catalytic domain that facilitates protein trans-splicing, resulting in the excision of the intein and the ligation of flanking extein sequences via a peptide bond (PMID: 23933386).

03

Biological functions

Protein trans-splicingPost-translational modificationProtein engineeringConditional protein activation
04

Disease associations

Gene therapy (delivery tool)Synthetic biology applications
05

Safety considerations

Immunogenicity of non-human protein fragmentsOff-target splicing if non-specific association occursEfficiency of splicing in different cellular environments

Beyond the preview

Go deeper on Gp41-1 split intein (Gp41-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gp41-1 split intein (Gp41-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call